Wexford Capital’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-38,292
Closed -$618K 316
2025
Q1
$618K Buy
+38,292
New +$618K 0.16% 103